Researchers report early findings that renal denervation's benefit to heart health may be independent of its treatment of hypertension, opening the door for novel indications for the technology.
MASSDEVICE ON CALL — Renal denervation, studied primarily in treatment of hypertension, may product benefits to heart health independent of those generated by lowering blood pressure, according to researchers reporting results from a small study.
The clinicians cautioned that the results are very early and need confirmation from a larger study, but were worked up about the findings.
Bolton Medical launches a U.S. phase II clinical trial for its Treovance abdominal stent graft system and Navitel delivery system.
Bolton Medical launched phase II of its U.S. clinical trial for its Treovance abdominal stent graft system and corresponding Navitel delivery system.
The Treovance stent graft is designed to be adaptable and flexible in order to accommodate a wide range of anatomies. The Navitel delivery system includes a proximal clasping system for precise delivery.
The phase II study will treat 150 patients with infrarenal aortic aneurysms, enrolled at 30 institutions located throughout the U.S., according to the press release.
The Emergo Group Blog provides short updates on quality and regulatory topics that may be of interest to QA/RA professionals in the medical device and IVD industry. No fluff, just straight to the point. We hope you'll enjoy the content.